- Other Enzymes
- Non-Enzymatic Dissociation Products
Cell Dissociation Market size was estimated to be valued at USD 402.6 million in 2022 and is poised to grow at a significant CAGR of 12.5% over 2023-2029. Cell dissociation, also known as trypsinization, is a procedure that uses a proteolytic enzyme to aid in the breakdown of protein to separate adherent cells from the cell culture medium. This breakdown is required so that the cells can be employed again. Cell dissociation reagents can perform proteolytic and collagenolytic actions to detach cell tissues and lines from the glass and plastic surfaces of the container, increasing cell survival and isolation efficiency. The cell dissociation agent chosen is determined by the tissue products or cell type and the age of the cells in the culture medium. Based on the product, the global cell dissociation market is segmented into Enzymatic Dissociation Products, Non-Enzymatic Dissociation Products, and Instruments. The Enzymatic Dissociation Products segment is anticipated to grow at a significant CAGR over the forecast years. The large share of this segment can be attributed increasing incidence of research. Cell dissociation reagents can perform proteolytic and collagenolytic actions to detach cell tissues and lines from the glass and plastic surfaces of the container, increasing cell survival and isolation efficiency. The cell dissociation agent chosen is determined by the tissue or cell type and the age of the cells in the culture medium. The predominance of cell-based research launched by many pharmaceutical and biotechnology businesses is driving the expansion of the cell dissociation industry. Furthermore, the number of pharmaceutical and biotechnology enterprises is growing globally. As a result, this is yet another aspect driving the cell dissociation industry forward.
Cell Dissociation Market Key Developments:
In 2020, Thermo Fisher Scientific partnered with Symphogen (Denmark) to Extend its strategic collaboration with Symphogen to advance biopharmaceutical discovery and development.
Fastest Growing Market
The market has expanded due to biopharmaceutical companies investing in research and development. Cell dissociation is critical in biopharmaceutical research since it is directly tied to medicine development and pathophysiology. The biopharmaceutical sector of the pharmaceutical industry is rapidly expanding, with substantial implications for healthcare. Opportunities in the field of biopharmaceuticals have grown in the last ten years because of their high efficacy and safety. The market for biopharmaceutical products has grown due to their advantages, such as their very potent and effective action, typical side effects, and ability to cure diseases rather than only treat their symptoms. The growing emphasis on investment and R&D in the pharmaceutical and healthcare sectors is driving market expansion. The Cell Dissociation Market is predicted to grow due to increased funding from various government agencies and commercial enterprises, the development of improved tissue dissociation enzyme products, and other factors.
VitaCyte, LLC., BD, Thermo Fisher Scientific Inc., PAN-Biotech, Merck KGaA, HiMedia Laboratories, Miltenyi Biotec GmbH, STEMCELL Technologies Inc., General Electric Company, and ATCC are the major players in the market.
Rising focus on expenditure and research and development in the pharmaceutical and healthcare industry is a few factors fueling the market growth.
The Global Cell Dissociation Market is Segmented based on Product, Tissue, End-User, and Geography.